These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7288193)

  • 21. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M; Sasamori E; Chiba T; Hanyu Y
    J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.
    Harris JF; Hawley RG; Hawley TS; Crawford-Sharpe GC
    J Immunol Methods; 1992 Apr; 148(1-2):199-207. PubMed ID: 1373425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential generation of monoclonal IgG-producing hybridomas by use of vesicular stomatitis virus-mediated cell fusion.
    Nagata S; Yamamoto K; Ueno Y; Kurata T; Chiba J
    Hybridoma; 1991 Jun; 10(3):369-78. PubMed ID: 1655635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Density separation of spleen cells increases fusion frequency and yield of Ig-producing hybridomas.
    Van Mourik P; Rivero RA; Van der Kwast TH; Lansdorp PM; Zeijlemaker WP
    J Immunol Methods; 1984 Mar; 68(1-2):45-53. PubMed ID: 6323584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a murine hybridoma secreting monoclonal anti-DNA autoantibody.
    Tron F; Charron D; Bach JF; Talal N
    J Immunol; 1980 Dec; 125(6):2805-9. PubMed ID: 7191869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiotypic network: study with hybridoma technology.
    Cazenave PA; Le Guern C; Legrain P; Juy D; Buttin G
    Transplant Proc; 1980 Sep; 12(3):405-8. PubMed ID: 7222220
    [No Abstract]   [Full Text] [Related]  

  • 27. A Bioassay for Optimization of Macrophage-Conditioned Medium as a Culture Supplement to Promote Hybridoma Cell Survival and Growth.
    Hnasko R; Lin AV; Stanker L; McGarvey J
    Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):126-133. PubMed ID: 29901420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of monoclonal antibodies in basic research, diagnosis, and therapy.
    Abell CW; Denney RM
    J Nat Prod; 1985; 48(2):193-202. PubMed ID: 3891919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of mouse T cell hybridomas.
    Kruisbeek AM
    Curr Protoc Immunol; 2001 May; Chapter 3():3.14.1-3.14.11. PubMed ID: 18432780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hybridoma cloning by the end-point dilution method].
    Novokhatskiĭ AS; Malakhova IV; Mikheeva TG
    Vopr Virusol; 1985; 30(5):602-8. PubMed ID: 3907143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryopreservation of newly formed hybridomas.
    De Leij L; Poppema S; The TH
    J Immunol Methods; 1983 Aug; 62(1):69-72. PubMed ID: 6875266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and characterization of mouse hybridomas.
    Mechetner E
    Methods Mol Biol; 2007; 378():1-13. PubMed ID: 18605074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of hybridoma technology to assess the antibody repertoire to a negatively charged hapten.
    Bankert RB; Mayers GL
    Transplant Proc; 1980 Sep; 12(3):409-12. PubMed ID: 7222221
    [No Abstract]   [Full Text] [Related]  

  • 34. An improved electrofusion technique for production of mouse hybridoma cells.
    Vienken J; Zimmermann U
    FEBS Lett; 1985 Mar; 182(2):278-80. PubMed ID: 3979550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poisson statistical analysis of repetitive subcloning by the limiting dilution technique as a way of assessing hybridoma monoclonality.
    Coller HA; Coller BS
    Methods Enzymol; 1986; 121():412-7. PubMed ID: 3724479
    [No Abstract]   [Full Text] [Related]  

  • 36. Human lymphocyte hybridomas and monoclonal antibodies.
    Carson DA; Freimark BD
    Adv Immunol; 1986; 38():275-311. PubMed ID: 3008522
    [No Abstract]   [Full Text] [Related]  

  • 37. Generation of novel killer hybridomas derived from proliferation-suppressed somatic cell hybrids between YACUT T cell lymphoma and normal lymphocytes activated in secondary mixed lymphocyte cultures.
    Kubota K; Nakazato K; Tamauchi H; Sasahara T; Katoh H
    J Immunol Methods; 1996 Jun; 192(1-2):137-47. PubMed ID: 8699010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitomycin C-treated 3T3/B (3T3/A31) cell feeder layers in hybridoma technology.
    Butcher RN; McCullough KC; Jarry C; Bryant J
    J Immunol Methods; 1988 Mar; 107(2):245-51. PubMed ID: 3126245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas.
    Karsten U; Stolley P; Walther I; Papsdorf G; Weber S; Conrad K; Pasternak L; Kopp J
    Hybridoma; 1988 Dec; 7(6):627-33. PubMed ID: 3235098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial cell growth supplements for promoting the growth of monoclonal antibody-producing hybridoma cells.
    Ransom JH
    Methods Enzymol; 1986; 121():293-5. PubMed ID: 3724467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.